American Board of Pathology (ABPath) · Current ABPath Cytopathology Content Specifications, designated Final Version and dated 1/2026, together with the examination blueprint marked Updated for 2026. Neither document states a separate effective date. Examination identity, the final-specifications index, the January 2026 specifications and the issuer's blueprint link were independently reopened on 2026-10-09. Complete blueprint percentages come from the supplied trusted frozen primary-issuer extract retrieved at 2026-10-09T04:58:57.193220+00:00, not a newly readable live table. Both percentage columns independently total 100%. The workbook label maps directly to ABPath's Cytopathology subspecialty certification examination; the assigned slug is preserved. The three retained domains are examination-description groupings. Their crosswalk explicitly preserves the shared genital category, whose 13% Written/Practical and 14% Virtual Microscopy weights include male GU specimens and cannot be attributed entirely to the narrower Gynecologic/Anal domain.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• ABPath Cytopathology Exam Description
• ABPath Content Specifications for Examinations
• ABPath Cytopathology Content Specifications, January 2026
• ABPath Guidelines and Key Manuscripts
• IARC Cervical Cytology Atlas: LSIL
• IARC Cervical Cytology Atlas: HSIL
• ASCCP: Unsatisfactory Cytology
• CAP-ASCCP LAST Recommendations
• ATA: Thyroid Cytopathology and Histopathology Quality Assurance
• The 2023 Bethesda System for Reporting Thyroid Cytopathology
• ATA Medullary Thyroid Carcinoma Guidelines, 2015
• Brescia Panel Study: Claudin-4 and BAP1 in Pleural Cytology
• EAU Non-Muscle-Invasive Bladder Cancer Guidelines, March 2026
• IASLC Diagnostic Immunohistochemistry Recommendations, April 2019
• CAP: Collection and Handling of Thoracic Cytology Specimens
• European Pancreatic Cystic Neoplasm Guidelines, 2018
• Original Study of Oncocytoma and Warthin Tumor Aspirates
• Original Mucoepidermoid Carcinoma Cytohistologic Correlation Study
• Milan System, Second Edition: Neoplasm Chapter
• CAP-ASCP: Laboratory Workup of Lymphoma in Adults
• ASCO-CAP Breast ER/PgR Testing Guideline Update, 2020
• 42 CFR 493.1274: Cytology
• CAP IHC Analytic Validation Recommendations, 2024
• FDA Statistical Guidance for Diagnostic-Test Studies
• CDC Clinical Overview of HPV
• ATA: NIFTP
• ABPath Cytopathology Examination Blueprint, updated for 2026
• ABPath Subspecialty Exam Blueprints and Daily Exam Schedules
• The 2023 Bethesda System for Reporting Thyroid Cytopathology: Original Publication PDF
• The Brescia Panel: Original Claudin-4 and BAP1 Study
• Diagnostic Performance of FNA Cytology in Mucoepidermoid Carcinoma
• ABPath Releases Candidate Resource Guide for Exam Preparation
• ABPath Candidate Resource Guide, 2026
• Diagnostic Accuracy and Pitfalls in Fine-Needle Aspiration Interpretation of Warthin Tumor
• ABPath 2026 Cytopathology (CY) Exam Schedule
• Visually recovered ABPath Cytopathology2026 weighted blueprint
• JBJI - Guideline for management of septic arthritis in native joints (SANJO)
• Diagnostic performance of fine needle aspiration cytology in the preoperative identification of mucoepidermoid carcinoma: a cross-sectional diagnostic analytical study
• Epidemiology Aetiology and Pathology - EAU Guidelines on RCC - Uroweb
• CFR-2025-title42-vol5-part493.pdf
• CFR-2022-title42-vol5-part493.pdf
• The cytological diagnosis of <i>Pneumocystis jiroveci</i> pneumonia in bronchoalveolar lavage - CytoJournal
• Thymoma%20T-Cell%20Flow.pdf